3.06.20
In April the Senate established the Select Committee on COVID-19 to inquire into the Australian Government's response to the pandemic, inviting submissions from industry and the community. The ASA completed its submission to the Committee last week, to ensure that author and illustrator voices are heard by government.
Our view is that there has been an immediate loss of income from cancelled appearances at schools, libraries and festivals; cancelled promotional tours and launches; cancelled or deferred workshops through the State and Territory Writers Centres (a significant employer of writers through their workshops); and the evaporation of casual work as teachers in schools and some universities which many authors use to supplement their income.
Even more significant, however, is the looming decline in royalties. We've seen bookshops across Australia temporarily close or reduce trading and the entire retail sector has contracted. In our view, the fall-out from COVID-19 for writers and illustrators will be slow and long, in contrast to the Government income assistance which is temporary and expires on 27 September. This is because:
We have not yet been able to quantify the full economic impact of COVID-19 on authors and illustrators because so many of the consequences are still ahead of us. In early October, the ASA will run its Annual Survey and the data we collect will be crucial this year. We will rely on your feedback to inform our advocacy. If any of you have reports from Nielsen Book about your book sales which you would be willing to share with the ASA (on a confidential basis if you'd prefer) as a case study, we'd be grateful to hear from you.
In our submission, we requested:
The full details of the ASA submission will be published on the parliamentary website here.
The Select Committee is due to present its final report on or before 30 June 2022. We’ll be sure to keep you up to date with any further developments.
Keep up-to-date with ASA advocacy, support and advice
with our fortnightly newsletter.